Inke S.A., a wholly owned subsidiary of Neuraxpharm, has been dedicated to the development and production of high-quality Active Pharmaceutical Ingredients (APIs) with intricate synthesis processes, primarily for application in respiratory and central nervous system (CNS) therapies since 1980. The company, based in Barcelona (Spain) and with over two decades of expertise in micronization, has been continuously expanding internationally since 1998, supplying APIs globally, including the US, Europe, and Japan. Inke has been consistently recognized for its quality and has undergone successful inspections by major global authorities, with the most recent US-FDA inspection taking place in May 2019. Over the past twenty years, the company has made significant progress in establishing itself as a reputable provider of respiratory APIs for inhalation.
Products & Services
Aformoterol Tartrate
API Custom Synthesis and Manufacturing
API Custom Synthesis & Manufacturing
Api Development Services
Sites
Inke S.A.
Country
City
Address
Inke, Grupo vita
Country
City
Address
Country
City
Address
Country
City
Address
Country
City
Address